AIFA – Nuove modalità compilazione Piano Terapeutico Incretine
(03/09/2014) http://www.agenziafarmaco.gov.it/it/content/nuove-modalit%C3%A0-compilazione-piano-terapeutico-incretine-03092014
Leggi
Breaking news
Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus: A Scientific Statement From the American Heart Association
David M. Maahs, Stephen R. Daniels, Sarah D. de Ferranti Circulation. published online August 28, 2014 http://circ.ahajournals.org/content/early/2014/08/28/CIR.0000000000000094
Leggi
FDA Drug Safety Communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain
28/08/2015 The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling. We have added a new Warning and Precaution about this risk to the labels of all medicines in this…
Leggi
FDA approves weight-management drug Contrave
September 10, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm413896.htm
Leggi
Nota Informativa AIFA su quetiapina
27/08/2015 L'Agenzia Italiana del Farmaco rende note importanti informazioni di sicurezza per il corretto uso della quetiapina nel trattamento della depressione bipolare e raccomanda il monitoraggio e la gestione dei cambiamenti dei parametri metabolici (cambiamenti lipidici, iperglicemia e diabete mellito) e dell’aumento di peso durante l'uso del medicinale in tutte…
Leggi
FDA revises label of diabetes drug canagliflozin (Invokana, Invokamet) to include updates on bone fracture risk and new information on decreased bone mineral density
The U.S. Food and Drug Administration has strengthened the warning for the type 2 diabetes medicine canagliflozin related to the increased risk of bone fractures and added new information about decreased bone mineral density http://www.fda.gov/Drugs/DrugSafety/ucm461449.htm
Leggi
FDA approves Trulicity to treat type 2 diabetes
September 18, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm415180.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Leggi
FDA clears glucose monitoring system for use in hospital critical care units
September 24, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm416144.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Leggi
Comunicazione EMA su farmaci contenenti testosterone
21/11/2014 http://www.agenziafarmaco.gov.it/sites/default/files/Testosterone-CMDh_IT.pdf
Leggi
FDA approves weight-management drug Saxenda
FDA December 23, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm
Leggi